Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial

por Garcia-Prats, Anthony J., Frias, Melchior, van der Laan, Louvina, De Leon, Anjanette, Gler, Maria Tarcela, Schaaf, H. Simon, Hesseling, Anneke C., Malikaarjun, Suresh, Hafkin, Jeffrey
Publicado 2022